What is the VolitionRx Limited stock price forecast?

VolitionRx Limited is currently trading at $0.72. View real-time AI analysis on Alpha Lenz.

What is VolitionRx Limited insider trading activity?

View the latest insider trading data for VolitionRx Limited on Alpha Lenz.

What is VolitionRx Limited's P/E ratio?

VolitionRx Limited's P/E ratio is -0.2.

VolitionRx Limited

NYSE · VNRX

$0.72-0.08(-10.24%)Market closed

Ask about VolitionRx Limited's future dividend policy...

Alpha Chat Insight

“VolitionRx Limited trades at a P/E of -0.2 (undervalued) with strong ROE of 79.0%. 3Y revenue CAGR of 78.0% highlights clear growth momentum.”

Ask for details →

Company Overview

VolitionRx Limited is a biotech company focused on developing blood tests for detecting a range of cancers and other diseases. Utilizing its innovative Nu.Q platform, VolitionRx aims to provide non-invasive, cost-effective diagnostic solutions that facilitate early detection and improve patient outcomes. The company's core technology revolves around identifying unique nucleosomes circulating in the blood, indicative of cancer and other conditions. By targeting broad applications in oncology, VolitionRx positions itself at the forefront of health diagnostics, impacting sectors such as healthcare, pharmaceuticals, and medical research. Headquartered in Austin, Texas, with a significant presence in Belgium, VolitionRx collaborates with leading institutions to validate its diagnostic tools. As precision medicine and early diagnosis continue to receive heightened focus in the medical community, VolitionRx's cutting-edge solutions hold a vital role in advancing healthcare and potentially saving lives through earlier intervention.

CEOMr. Cameron Reynolds MBA

Websitehttps://volition.com

SectorHealthcare

IndustryMedical Devices

Employees70

Company Statistics

FY 2025

Profile

$3.84MMarket Cap

$1.73MRevenue

0.00Shares Out

70Employees

Margins

N/AGross

-1158.11%EBITDA

-1228.57%Operating

-1360.63%Pre-Tax

-1360.63%Net

Valuation

-0.16P/E

-0.11P/B

2.22EV/Sales

-0.64EV/EBITDA

-0.19P/FCF

Growth (CAGR)

77.98%Rev 3Yr

164.15%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-288.37%ROA

78.97%ROE

-257.83%ROIC

Financial Health

$1.12MCash & Cash Equivalents

$41.38MNet Debt

-119.39%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“VolitionRx Limited trades at a P/E of -0.2 (undervalued) with strong ROE of 79.0%. 3Y revenue CAGR of 78.0% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

VolitionRx Limited (ticker: VNRX) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 70 employees. Market cap is $4M.

The current price is $0.718 with a P/E ratio of -0.16x and P/B of -0.11x.

ROE is 78.97% and operating margin is -1228.57%. Annual revenue is $2M.